Ralmitaront
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ralmitaront, covering 2025-03-17 to 2025-03-17. Get the full timeline:
Most recent: Clinical Trial Update: 18F-Dihydroxyphenylalanine (DOPA) Positron Emission Tomography (PET) Study to Explore Dopamine Synthesis Capacity in the Whole Striatum After 2 Weeks of Treatment With Ralmitaront or Placebo in Participants With Schizophrenia [Phase 1]